Fortis seeks CCI nod to buy 31.52% more in diagnostics subsidiary Agilus

Fortis Healthcare has sought approval from the Competition Commission of India to acquire an additional 31.52% stake in its diagnostics arm, Agilus, raising its shareholding to 89.2%. The deal, valued at ₹1,780 crore, involves buying stakes from private equity players. Additionally, Aquilo House Pte seeks approval to acquire a 26.47% stake in Aavas Financiers.